# Structural and Organizational Critique
## Systematic Literature Review on Wearable Seizure Detection

**Date:** 2026-01-26
**Document:** Literature Review on Deep Learning for Seizure Detection and Prediction from Non-EEG Wearable Signals (2013-2026)
**Reviewer:** Academic Editor Analysis

---

## Executive Summary

This systematic review demonstrates strong content organization overall, with clear separation between detection and forecasting applications. However, several structural issues require attention before the document reaches publication readiness. The most significant concerns are:

1. **Redundancy between Results and Discussion sections** (HIGH severity)
2. **Inconsistent Webster & Watson framework implementation** (MEDIUM severity)
3. **Missing Background section** (commented out in main.tex) (MEDIUM severity)
4. **Page distribution imbalance** (MEDIUM severity)
5. **Table integration issues** (LOW-MEDIUM severity)

The paper would benefit from consolidating overlapping content and ensuring each section performs its distinct function: Results for describing findings, Discussion for interpreting them.

---

## 1. Section Organization Analysis

### 1.1 Current Structure (from main.tex)

```
Abstract (Section 0)
Introduction (Section 1)
Methods (Section 3)
  - Search Strategy (Section 3.1)
  - PRISMA flow diagram
Tables Section (unnumbered)
Results (Section 4)
  - 9 subsections
Discussion (Section 5)
  - 4 subsections
Conclusion (Section 6)
Bibliography
```

### 1.2 Structural Issues

#### Issue 1.1: Missing Section Numbering
**Severity:** LOW

**Location:** `/home/paulin/Documents/Epilepsie/main.tex` lines 80-96

**Observation:** The Tables section uses `\section*{Tables}` without numbering, but it appears between Methods and Results. This creates an unusual structural break in the narrative flow.

**Recommendation:** Either:
- Move tables to an appendix (if they are primarily reference material)
- Integrate tables into the Results section with proper narrative introductions
- Keep as is but justify in a methods note that tables serve as the concept matrix reference

---

#### Issue 1.2: Background Section is Commented Out
**Severity:** MEDIUM

**Location:** `/home/paulin/Documents/Epilepsie/main.tex` line 82

**Observation:** The Background section (`02_Background2.tex`) is commented out. The Introduction jumps directly from problem statement to research question without providing necessary context on:
- What epilepsy is (beyond prevalence statistics)
- Different seizure types (focal vs generalized, convulsive vs non-convulsive)
- ILAE phases and their significance
- Current state of EEG-based monitoring (what is being replaced/improved)

**Impact:** Readers without specialized epilepsy knowledge may struggle to understand the clinical significance of findings. The Abstract mentions "ILAE Phase 3 benchmark" but this is never explained in the body text.

**Recommendation:** Either restore the Background section or integrate essential background information into the Introduction. At minimum, the Introduction should define:
- ILAE phases
- Seizure classification (convulsive vs non-convulsive)
- Why FPR thresholds matter clinically

---

## 2. Webster & Watson Framework Compliance

### 2.1 Claimed Framework

**Location:** `/home/paulin/Documents/Epilepsie/Sections(tex)/03_Methods.tex` lines 2-4

> "The review follows structured IS/medical literature guidance (concept matrix inspired by \parencite{websterAnalyzingPrepareFuture2002} and PRISMA principles \parencite{tugwellPRISMA20202021})."

**Location:** `/home/paulin/Documents/Epilepsie/Sections(tex)/00_Abstract.tex` line 7

> "Following PRISMA guidelines and the Webster & Watson concept matrix framework..."

### 2.2 Webster & Watson Requirements

The Webster & Watson (2002) concept matrix approach requires:

1. **A comprehensive table** identifying all concepts/studies
2. **Grouping of studies by concept/theme**
3. **Analysis across dimensions** rather than study-by-study
4. **Clear organization** that facilitates comparison

### 2.3 Implementation Assessment

#### Strengths

| Element | Status | Evidence |
|---------|--------|----------|
| Study Matrix Tables | PRESENT | Tables 1a (detection) and 1b (forecasting) provide study-level overview |
| Architecture Deep-Dive Tables | PRESENT | Tables 2a and 2b provide technical details |
| Metrics Summary Table | PRESENT | Table 3 provides cross-study metric counts |
| Dimensional Analysis | PARTIAL | Results organized by dimensions (modality, architecture, performance) |

#### Weaknesses

**Issue 2.1: Narrative-Table Disconnect**

**Severity:** MEDIUM

**Observation:** The Results section is organized by dimensions (modality, architecture, performance) which aligns with Webster & Watson. However, the narrative frequently re-describes data already present in tables without adding interpretive value.

**Example from `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/02_modality_performance.tex` lines 7-11:**

> "Accelerometer data appears in nine of 13 studies (69%). Six detection studies and three forecasting studies use accelerometry. Electrodermal activity appears in five studies (38%). ECG or HRV data appears in five studies. PPG appears in four studies. Gyroscope data appears in three studies, all in detection applications."

This information could be summarized with a table reference, allowing the narrative to focus on patterns and implications rather than counting.

**Recommendation:** Use tables for descriptive statistics. Reserve Results narrative for:
- Identifying patterns
- Highlighting unexpected findings
- Explaining anomalies
- Setting up interpretation that will occur in Discussion

---

**Issue 2.2: Missing Concept Synthesis**

**Severity:** MEDIUM

**Observation:** Webster & Watson emphasizes organizing by concept (e.g., "modalities that work," "architectures that scale") rather than by study listing. The current Results section does this partially but could be more explicit about conceptual groupings.

**Current Structure:**
- Study Characteristics (study-by-study)
- Modality Performance (conceptual)
- Architecture Patterns (conceptual)
- Architectures and Personalization (conceptual - but overlaps with above)
- Performance Metrics (study-by-study listing)
- Detection vs Forecasting (conceptual)
- Clinical Readiness (conceptual)
- Detection, Forecasting, and Clinical Readiness (redundant with above)

**Recommendation:** Consider consolidating into four clear conceptual dimensions:
1. **What was studied** - Study characteristics and settings
2. **How they approached it** - Modalities, architectures, and personalization
3. **What they found** - Performance metrics and benchmarks
4. **What it means clinically** - Readiness for deployment

This would eliminate the redundancy between sections 07, 08, and 09.

---

## 3. Redundancy Analysis

### 3.1 Major Redundancies

#### Redundancy 1: Detection vs Forecasting Comparison

**Severity:** HIGH

**Locations:**
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/07_detection_vs_forecasting.tex` (entire section)
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/09_detection_forecasting_readiness.tex` lines 1-15
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Discussion/d1_clinical_implications.tex` lines 11-25

**Observation:** The comparison between detection and forecasting maturity appears in three separate places with substantial overlap.

**Content Example - Overlapping FPR benchmark discussion:**

*Results 07 (lines 15-16):*
> "Detection shows greater clinical maturity than forecasting. Two detection studies meet Phase 3 FPR benchmarks."

*Results 09 (lines 7-10):*
> "Detection shows greater clinical maturity than forecasting. Two detection studies meet Phase 3 FPR benchmarks defined by the ILAE..."

*Discussion d1 (lines 11-13):*
> "The detection literature demonstrates that clinically acceptable FPR is achievable with accelerometer-based approaches (see ref). Two studies meet the ILAE Phase 3 benchmark using ACC data..."

**Recommendation:** Consolidate into one location:
- **Results:** Brief factual comparison with table references
- **Discussion:** Interpretive discussion of why this difference exists and its implications

---

#### Redundancy 2: Clinical Readiness Assessment

**Severity:** HIGH

**Locations:**
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/08_clinical_readiness.tex` (entire section, ~64 lines)
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/09_detection_forecasting_readiness.tex` (entire section, ~16 lines)
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Discussion/d1_clinical_implications.tex` lines 11-25

**Observation:** Clinical readiness is assessed twice in Results and again in Discussion, with similar content.

**Duplicate Content Examples:**

*Results 08, lines 10-12 (Spahr study):*
> "Two detection studies approach Phase 3 requirements. \textcite{spahrDeepLearningbasedDetection2025} conducted prospective multi-center validation with 384 patients. The study met clinical FPR benchmarks but was conducted in EMU settings rather than home."

*Results 09, lines 7-9:*
> "\textcite{spahrDeepLearningbasedDetection2025} achieved 0.0054/h FPR (approximately 1 false alarm per 8 days) with 96\% sensitivity in a prospective multi-center study of 384 patients."

*Discussion d1, lines 13-15:*
> "However, this achievement remains concentrated in controlled EMU settings rather than real-world home environments... The two studies achieving benchmark FPR were validated in hospital settings..."

**Recommendation:** Merge Results 08 and 09 into a single "Clinical Readiness" subsection. Keep Discussion focused on implications rather than re-stating findings.

---

#### Redundancy 3: Architecture Patterns

**Severity:** MEDIUM

**Locations:**
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/03_architecture_patterns.tex` (entire section)
- `/home/paulin/Documents/Epilepsie/Sections(tex)/Results/04_modalities_architectures.tex` lines 4-12

**Observation:** Architecture patterns are described in two separate sections with overlapping content.

**Example Overlap:**

*Results 03, lines 18-19:*
> "CNN-based approaches dominate detection research, with \textcite{spahrDeepLearningbasedDetection2025} implementing an ensemble of 30 CNN models..."

*Results 04, lines 6-8:*
> "CNN-based methods are prominent in detection. \textcite{spahrDeepLearningbasedDetection2025} implemented an ensemble of 30 CNN models, achieving 96\% sensitivity with 0.0054/h FPR."

**Recommendation:** These sections should be consolidated. The separation creates confusion about where to find specific architectural information.

---

#### Redundancy 4: EMU-to-Home Translation Gap

**Severity:** MEDIUM

**Locations:**
- Results 08 (lines 35-36): mentions hospital vs home environment difference
- Results 09 (implicitly): discusses Spahr's EMU validation vs Dong's home validation
- Discussion d1 (lines 13-15): explicitly labels "EMU-to-home translation gap"
- Discussion d3 (lines 9-11): mentions validation setting bias

**Observation:** The important insight about EMU validation overestimating real-world performance is scattered across multiple sections without a single, coherent presentation.

**Recommendation:** Present this key finding once with maximum impact:
- **Results:** State the factual difference (Spahr 0.0054/h in EMU vs Dong 0.165/h at home)
- **Discussion:** Label and explain the "EMU-to-home translation gap" and its implications

---

### 3.2 Specific Repeated Information

| Information | Results Location(s) | Discussion Location(s) |
|-------------|---------------------|------------------------|
| Only 2 detection studies meet ILAE Phase 3 FPR benchmark | Results 06, 08, 09 | Discussion d1 |
| Spahr 2025: 96% sens, 0.0054/h FPR, 384 patients | Results 02, 03, 04, 08, 09 | Discussion d1, Conclusion |
| Fine 2025: 100% sens, 0.023/h FPR | Results 02, 06, 08, 09 | Discussion d1, Conclusion |
| Forecasting AUC plateaus at 0.74-0.75 | Results 02, 06, 07, 09 | Discussion d1, d2, Conclusion |
| EMU validation may underestimate real-world FPR | Results 08, 09 | Discussion d1, d3 |
| Patient-specific models achieve 100% success vs 43% for global LOSO | Results 04, 09 | Discussion d2 |
| 69% of studies use multi-modal approaches | Results 02 | Discussion d2 |
| Only 3 of 13 studies are prospective | Results 01, 08 | Abstract |

---

## 4. Section-by-Section Analysis

### 4.1 Abstract

**File:** `/home/paulin/Documents/Epilepsie/Sections(tex)/00_Abstract.tex`

**Structure:** Properly organized with Background, Methods, Results, Conclusions subsections.

**Strengths:**
- Clear structure with labeled subsections
- Contains key quantitative findings
- Balanced presentation of strengths and limitations

**Issues:**

**Issue 4.1.1: Inconsistent Numbers with Results**
**Severity:** LOW

**Observation:** The abstract states "Two systems meet the ILAE Phase 3 benchmark" (line 10), but the ILAE Phase 3 benchmark requires prospective home validation. Both Spahr and Fine validated in EMU/hospital settings, not homes. Technically, these are Phase 2 studies that meet Phase 3 FPR targets, not Phase 3 studies.

**Recommendation:** Clarify wording: "Two studies meet the ILAE Phase 3 FPR target" (not "benchmark" and not "Phase 3 studies").

---

**Issue 4.1.2: Forecasting AUC Consistency**
**Severity:** LOW

**Observation:** Abstract states "AUC consistently plateaus around 0.74-0.75" (line 12), but Nasseri 2021 reports AUC 0.80 (mean). This is mentioned in Discussion but not clearly acknowledged in the abstract as an exception.

**Recommendation:** Either clarify "AUC generally plateaus around 0.74-0.75" or mention the Nasseri outlier.

---

### 4.2 Introduction

**File:** `/home/paulin/Documents/Epilepsie/Sections(tex)/01_introduction3.tex`

**Length:** 35 lines (appropriately concise)

**Strengths:**
- Clear problem statement
- Strong clinical motivation (69% preventable deaths)
- Explicit research question
- Appropriate length for a 15-page paper

**Issues:**

**Issue 4.2.1: Missing Clinical Context**
**Severity:** MEDIUM

**Observation:** The Introduction assumes reader familiarity with:
- What constitutes a "false alarm rate" and why it matters
- What ILAE phases are
- Difference between convulsive and non-convulsive seizures
- Why EEG is unsuitable for ambulatory use beyond "operational complexity"

**Recommendation:** Add 2-3 sentences defining these key concepts. Consider restoring a brief Background section or expanding the Introduction's Problem Statement subsection.

---

**Issue 4.2.2: Typo**
**Severity:** LOW

**Location:** Line 5

> "60 million people wordlwide"

**Recommendation:** Fix spelling: "worldwide"

---

**Issue 4.2.3: Grammar**
**Severity:** LOW

**Location:** Line 34

> "achieve a optimal trade-off"

**Recommendation:** Fix article: "achieve an optimal trade-off"

---

### 4.3 Methods

**File:** `/home/paulin/Documents/Epilepsie/Sections(tex)/03_Methods.tex`

**Structure:** Well-organized with clear subsections.

**Strengths:**
- Clear description of search strategy
- Inclusion/exclusion criteria explicitly stated
- Table dimensions well-defined
- PRISMA reference included

**Issues:**

**Issue 4.3.1: Search Strategy Separation**
**Severity:** LOW

**Observation:** The PICO-based search strategy is in a separate file (`3.1_Search Strategy.tex`) but only 3 lines of Methods content remain before it. This creates a somewhat disjointed Methods section.

**Recommendation:** Consider either:
- Merging Search Strategy into the main Methods file, or
- Adding transitional text to better connect the two files

---

**Issue 4.3.2: Inconsistent Year Range**
**Severity:** LOW

**Observation:**
- Abstract and Methods state "2013-2026"
- Search Strategy line 48 states "2015-2025"
- Search Strategy lines 42-44 explain expansion to 2013-2026 through exploration

**Recommendation:** Ensure consistency throughout. Either state the original range and explain the expansion in all relevant locations, or simply state the final range consistently.

---

### 4.4 Results Section

**Structure Assessment:**

| File | Lines | Purpose | Redundancy Level |
|------|-------|---------|------------------|
| results_main.tex | 19 | Main container/overview | None |
| 01_study_characteristics.tex | 14 | Sample sizes, designs, settings | Low |
| 02_modality_performance.tex | 36 | Modality usage and performance | Medium (see 04) |
| 03_architecture_patterns.tex | 28 | Learning paradigms, evolution | High (with 04) |
| 04_modalities_architectures.tex | 46 | Architecture details, personalization | High (with 03) |
| 06_performance_metrics.tex | 21 | Sensitivity, FPR, forecasting metrics | Medium (with 08) |
| 07_detection_vs_forecasting.tex | 28 | Comparison of two applications | High (with 09) |
| 08_clinical_readiness.tex | 64 | Validation, commercial status, barriers | High (with 09) |
| 09_detection_forecasting_readiness.tex | 16 | Maturity comparison | High (with 07, 08) |

**Total Results lines:** approximately 272 lines

**Issue 4.4.1: Excessive Subsectioning**
**Severity:** MEDIUM

**Observation:** Nine Results subsections create fragmentation. Several subsections (03/04, 07/08/09) cover overlapping territory.

**Recommendation:** Consolidate to 4-5 subsections:
1. Study Characteristics (merge 01)
2. Modalities and Architectures (merge 02, 03, 04)
3. Performance Metrics (merge 06)
4. Clinical and Translation Readiness (merge 07, 08, 09)

---

**Issue 4.4.2: Forward References Excessive**
**Severity:** LOW

**Observation:** Many subsections forward-reference others rather than presenting complete information:

*02_modality_performance.tex, line 27:*
> "Additional modality performance details are provided in Sections~\ref{sec:modalities-architectures} and~\ref{sec:detection-vs-forecasting}."

*03_architecture_patterns.tex, line 18:*
> "Detailed descriptions of specific architectures are provided in Section~\ref{sec:modalities-architectures}."

**Recommendation:** Either consolidate related content or ensure each subsection can stand alone. Excessive forward references disrupt reading flow.

---

### 4.5 Discussion Section

**Structure Assessment:**

| File | Lines | Purpose |
|------|-------|---------|
| discussion.tex | 14 | Overview/roadmap |
| d1_clinical_implications.tex | 26 | Coverage gap, detection readiness, forecasting status |
| d2_technical_insights.tex | 32 | Modality paradox, architecture, personalization, FPR |
| d3_limitations.tex | 16 | Sample size, validation bias, reporting, cold-start |
| d4_future_directions.tex | 22 | Nine research priorities |

**Total Discussion lines:** approximately 110 lines

**Issue 4.5.1: Discussion Repeats Results**
**Severity:** MEDIUM

**Observation:** Multiple Discussion subsections repeat numerical findings from Results without adding interpretation.

**Example from d1_clinical_implications.tex, lines 13-15:**
> "Two studies meet the ILAE Phase 3 benchmark using ACC data, suggesting that motor seizure detection has reached sufficient maturity for clinical translation."

This repeats Results 06 (line 10) and Results 08 (line 10) without adding new interpretation beyond what was already stated.

**Recommendation:** Discussion should focus on:
- **Why** findings matter (not restating **what** the findings are)
- **Mechanisms** underlying observed patterns
- **Implications** for practice, policy, or future research
- **Limitations** of the evidence base
- **Synthesis** across dimensions

**Issue 4.5.2: d3_limitations Cites Results Instead of Stating Directly**
**Severity:** LOW

**Observation from d3_limitations.tex, line 11:**
> "Hospital environments lack the diversity of daily activities that generate false alarms in home settings as discussed in \ref{EMU-to-home}"

**Recommendation:** Self-referencing within Discussion creates circular structure. State the point directly or reference Results, not Discussion subsections.

---

### 4.6 Conclusion

**File:** `/home/paulin/Documents/Epilepsie/Sections(tex)/conclusion.tex`

**Length:** 13 lines

**Strengths:**
- Synthesizes key findings without simply repeating
- Identifies three clear gaps
- Provides specific recommendations
- Appropriate length

**Issues:**

**Issue 4.6.1: Repeats Specific Study Results**
**Severity:** LOW

**Observation:** Lines 6-7 repeat Spahr and Fine's specific numbers that have appeared multiple times throughout the paper.

**Recommendation:** The Conclusion should focus on the synthesis ("accelerometer-based approaches converge on a single modality") rather than repeating individual study statistics.

---

## 5. Table Integration

### 5.1 Current Table Structure

| Table | Content | Location in main.tex | Narrative Integration |
|-------|---------|---------------------|----------------------|
| 1a | Detection Studies Matrix | Between Methods and Results | Referenced in results_main.tex |
| 1b | Forecasting Studies Matrix | Between Methods and Results | Referenced in results_main.tex |
| 2a | Detection Architecture Deep-Dive | Between Methods and Results | Referenced in results_main.tex |
| 2b | Forecasting Architecture Deep-Dive | Between Methods and Results | Referenced in results_main.tex |
| 3 | Metrics Summary | Between Methods and Results | Referenced in results_main.tex |

### 5.2 Integration Issues

**Issue 5.2.1: Tables Come Before Narrative**
**Severity:** MEDIUM

**Observation:** All five tables are placed between Methods and Results (main.tex lines 86-93). The Results narrative (line 94) comes after, meaning readers encounter detailed tables before any narrative introduction to what they contain.

**Standard Practice:** Either:
- Tables appear first in Results with narrative introduction
- Tables appear in Results after narrative introduction, interspersed with relevant subsections

**Recommendation:** Add a brief narrative paragraph before the tables explaining:
- What the tables contain
- How to read them (abbreviations, organization)
- What key dimensions they capture

---

**Issue 5.2.2: Insufficient Table Interpretation**
**Severity:** LOW-MEDIUM

**Observation:** Tables contain rich data but Results subsections often restate table contents rather than interpreting patterns.

**Example:** Table 1a shows detection studies with columns for Paradigm, Modality, Personalization. Results subsections could identify patterns (e.g., "Ensemble methods are exclusively used in detection applications") but instead often restate study-level details.

**Recommendation:** Use Results narrative to highlight patterns visible in tables, not to re-describe individual rows.

---

## 6. Page Distribution and Balance

### 6.1 Estimated Page Distribution

Based on line counts and typical LaTeX formatting (12pt, A4, standard margins):

| Section | Approximate Lines | Estimated Pages | Percentage |
|---------|------------------|-----------------|------------|
| Abstract | 18 | 0.25 | 2% |
| Introduction | 35 | 0.5 | 4% |
| Methods | 83 | 1 | 7% |
| Tables | ~200 | 3-4 | 25% |
| Results | ~272 | 3-4 | 25% |
| Discussion | ~110 | 1.5 | 12% |
| Conclusion | 13 | 0.25 | 2% |
| Bibliography | - | 1-2 | 10% |
| **TOTAL** | ~731 | ~13-15 | 100% |

### 6.2 Balance Issues

**Issue 6.2.1: Tables Take Significant Space**
**Severity:** LOW

**Observation:** Tables occupy approximately 25% of the document. This is appropriate for a concept matrix approach but requires justification.

**Recommendation:** This is acceptable given the Webster & Watson framework. Consider referencing this approach explicitly to justify the extensive tabular presentation.

---

**Issue 6.2.2: Discussion May Be Underdeveloped**
**Severity:** MEDIUM

**Observation:** Discussion represents only about 12% of the document (~1.5 pages). For a systematic review, Discussion should typically be 20-25% of the body text, as this is where synthesis occurs.

**Current Distribution:** Results (3-4 pages) vs Discussion (1.5 pages) = 2:1 ratio

**Ideal Distribution:** Results and Discussion should be more balanced, possibly 1:1 or 3:2

**Recommendation:** Expand Discussion by:
- Adding more interpretive depth (not just repeating Results)
- Including comparison to other reviews (if applicable)
- Discussing implications for different stakeholders (clinicians, patients, device manufacturers, regulators)
- Elaborating on mechanisms underlying observed patterns

---

**Issue 6.2.3: Introduction Is Brief**
**Severity:** LOW

**Observation:** Introduction is approximately 0.5 pages. For a 15-page review, 1 page (7%) would be more standard to establish sufficient context.

**Recommendation:** Consider expanding Introduction to:
- Define key clinical concepts (ILAE phases, seizure types)
- Provide brief background on traditional ML approaches (as contrast to DL)
- More thoroughly motivate the research question

---

## 7. Missing Elements

### 7.1 Critical Missing Content

**Issue 7.1.1: ILAE Phase Definition**
**Severity:** MEDIUM

**Observation:** ILAE Phase 3 benchmark is referenced 8+ times but never defined. Readers unfamiliar with epilepsy research standards won't understand:
- What Phase 1, 2, 3 mean
- Why Phase 3 is the benchmark
- What distinguishes phases

**Recommendation:** Add to Introduction or early Methods:
> "The International League Against Epilepsy (ILAE) defines three phases of device development: Phase 1 (feasibility), Phase 2 (pilot validation), and Phase 3 (established performance). For ambulatory use, Phase 3 requires prospective validation in the intended use environment with false positive rates below 0.05-0.1 per hour."

---

**Issue 7.1.2: Seizure Type Definitions**
**Severity:** MEDIUM

**Observation:** The paper distinguishes between convulsive/non-convulsive and motor/non-motor seizures without defining these terms or explaining their clinical significance.

**Recommendation:** Add brief definitions explaining that:
- ~25-30% of PWE have generalized tonic-clonic seizures (convulsive)
- ~70-75% have focal seizures (may be non-convulsive)
- This explains why accelerometer-based devices serve only a subset

---

**Issue 7.1.3: Comparison to EEG-based Approaches**
**Severity:** LOW

**Observation:** The paper excludes EEG studies but doesn't provide context on how wearable approaches compare to EEG-based detection/forecasting in performance.

**Recommendation:** Brief mention in Discussion of how wearable performance compares to established EEG-based methods (e.g., "While EEG-based systems achieve >95% sensitivity with controlled FPR, wearable approaches...")

---

**Issue 7.1.4: Stakeholder Perspectives**
**Severity:** LOW

**Observation:** The paper focuses on technical performance but doesn't discuss implications for:
- Patients (quality of life, adherence)
- Clinicians (integration into practice)
- Payers/reimbursement
- Regulators

**Recommendation:** Consider adding a subsection in Discussion or Conclusion on practical implementation considerations.

---

## 8. Transitions and Flow

### 8.1 Section Transition Analysis

**Issue 8.1.1: Methods to Results Transition**
**Severity:** LOW

**Observation:** The transition from Methods to Results is abrupt. Methods ends with the PRISMA figure (line 83), then tables appear immediately.

**Current Structure:**
```
Methods -> PRISMA Figure -> Tables -> Results Header
```

**Recommendation:** Add a transition sentence after the PRISMA figure:
> "The following tables present the concept matrix for all included studies, organized by detection and forecasting applications. Section 4 synthesizes findings across multiple dimensions."

---

**Issue 8.1.2: Results to Discussion Transition**
**Severity:** LOW

**Observation:** Results ends with section 09 (detection/forecasting readiness) without a clear transition to Discussion.

**Recommendation:** Add a concluding paragraph to Results that summarizes key findings and introduces the Discussion structure.

---

**Issue 8.1.3: Conclusion Bibliography Citation in Conclusion**
**Severity:** LOW

**Observation:** The Conclusion section makes claims about commercial devices (FDA 510(k) clearance, CE approval) without citing sources.

**Location:** `/home/paulin/Documents/Epilepsie/Sections(tex)/conclusion.tex` line 10

**Recommendation:** Add citations for device approval claims.

---

## 9. Priority Recommendations

### 9.1 High Priority (Address Before Submission)

1. **Eliminate Results redundancy** (sections 07, 08, 09)
   - Consolidate detection vs forecasting comparison into one subsection
   - Merge clinical readiness assessment into one subsection
   - Remove repeated numerical summaries

2. **Restore or integrate Background content**
   - Either restore Background section or integrate key definitions into Introduction
   - Define ILAE phases, seizure types, and FPR clinical significance

3. **Expand Discussion**
   - Add more interpretation (less repetition)
   - Include comparison to other approaches (EEG-based)
   - Add stakeholder perspectives

4. **Clarify ILAE Phase 3 claim**
   - Distinguish between "meeting FPR target" vs "being a Phase 3 study"
   - Ensure consistent terminology throughout

### 9.2 Medium Priority (Improve Quality)

5. **Consolidate Results subsections**
   - Merge 03 and 04 (architecture patterns)
   - Reduce from 9 to 4-5 subsections
   - Minimize forward references

6. **Improve table integration**
   - Add narrative introduction before tables
   - Use Results to interpret patterns, not restate table contents

7. **Fix typos and grammar**
   - "wordlwide" -> "worldwide"
   - "a optimal" -> "an optimal"
   - Check for similar issues throughout

### 9.3 Low Priority (Polish)

8. **Add concluding transitions**
   - Results to Discussion
   - Methods to Results

9. **Add citations in Conclusion**
   - Support device approval claims

10. **Consider reorganizing section numbering**
    - Address Tables section numbering

---

## 10. Summary Assessment

### Strengths
- Clear research question and focus
- Comprehensive literature search (13 studies, 2013-2026)
- Strong tabular presentation following concept matrix approach
- Good separation of detection vs forecasting applications
- Appropriate length for a 15-page target
- Discussion of limitations included

### Areas for Improvement
- Significant redundancy between Results and Discussion
- Inconsistent implementation of Webster & Watson framework
- Missing clinical definitions (ILAE phases, seizure types)
- Discussion section may be underdeveloped relative to Results
- Tables placed before narrative introduction

### Overall Assessment

The paper demonstrates solid content organization and a clear conceptual framework. The primary structural issue is redundancy between Results and Discussion sections, which suggests the paper would benefit from a consolidation pass. The Webster & Watson concept matrix approach is partially implemented but could be more consistently applied throughout the Results narrative.

**Estimated revision effort:** 4-6 hours to address high-priority issues, 8-12 hours for comprehensive restructuring.

---

**End of Critique**
